Procter & Gamble, US7427181091

Procter & Gamble sets steady growth targets, shares hold S&P 500 blue-chip status

24.06.2026 - 07:13:30 | ad-hoc-news.de

Procter & Gamble maintains a cautious mid?single?digit growth outlook after a solid fiscal third quarter, with the consumer staples heavyweight remaining a core S&P 500 name for investors seeking stability.

Procter & Gamble, US7427181091
Procter & Gamble, US7427181091

By Thomas Klein, Operations & Strategy desk. Reviewed prior to publication on 2026-06-24, 07:10.

Procter & Gamble (US7427181091) continues to run with a moderate growth profile and tight cost control as it moves toward its fiscal year-end, with shares trading on the NYSE as part of the defensive S&P 500 consumer staples cohort. The group is guiding for all-in sales growth of 1 to 5 percent and diluted EPS growth of 1 to 6 percent for the current fiscal year after delivering a solid fiscal third quarter, according to its April earnings release and subsequent market coverage.

What recent results show

In its fiscal third quarter, Procter & Gamble reported net sales of about 21.24 billion dollars, an increase on the prior-year period driven by a mix of pricing and volume effects across categories such as fabric care, home care and personal care, according to company disclosures and analyst summaries. Adjusted earnings per share came in around 1.59 dollars, which was above the consensus compiled by major Wall Street houses and underpinned the decision to leave full-year guidance unchanged, as highlighted in a recent International Business Times analysis of the quarter.

The company reiterated a mid-single-digit organic sales growth ambition, with management pointing to balanced contributions from volume and net pricing as well as a disciplined focus on productivity and savings programs in procurement, manufacturing and overheads in North America and Europe. Consumer demand for core categories such as detergents, diapers and grooming remains relatively resilient, with trading-down limited compared with more discretionary segments, according to recent sell-side commentary from large brokers that cover the NYSE-listed name as a key benchmark in global household and personal care.

Analyst views and consensus

On the sell-side, Procter & Gamble is widely considered a high-quality defensive holding, with a sizeable proportion of analysts rating the stock at Buy or Overweight and the rest clustered in Hold, according to aggregated broker data from platforms such as MarketScreener and Bloomberg. Consensus models typically embed low- to mid-single-digit annual organic sales growth and a gradual margin recovery as input cost pressures in commodities and freight ease further, while foreign exchange remains a watchpoint for the multinational portfolio.

Dividend continuity also forms part of the investment case, with Procter & Gamble included in several dividend and low-volatility indices and recognized for its long record of annual dividend increases, making it a reference point in the US consumer staples peer group alongside companies such as Unilever and Colgate-Palmolive. A recent Reuters round-up of consumer staples earnings underlined that large-cap staples groups continue to benefit from steady demand and the ability to pass through selective price increases without a dramatic impact on volumes.

Go deeper

All news and analysis on the Procter & Gamble shares

Further updates on earnings, margins and guidance for The Procter & Gamble Company, plus historical price data and regulatory filings, can be found in the dedicated topic overview.

Where Procter & Gamble earns its money

Procter & Gamble generates its revenue globally through a portfolio of branded consumer products across five main segments: Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care, with leading brands in each category. Flagship offerings include Tide laundry detergent in fabric care, Pampers diapers in baby care, Gillette blades and razors in grooming, and Oral-B oral care products in health care, giving the company broad exposure to everyday household consumption worldwide.

Where the shares trade today

The Procter & Gamble shares (US7427181091) trade on the NYSE in US dollars as part of the S&P 500 consumer staples segment; the latest available composite quote in late June 2026 shows the stock changing hands around the mid-150-dollar range during regular US trading hours.

Key data on the Procter & Gamble shares

  • Company: The Procter & Gamble Company
  • ISIN: US7427181091
  • WKN: 852062
  • Ticker: PG
  • Trading venue: NYSE
  • Price (as of 2026-06-23, 22:00): 150.70 USD
  • Market cap: 355,000,000,000 USD (as of 2026-06-23)
  • Sector / industry: Consumer Staples / Household & Personal Products
  • Index membership: S&P 500, Dow Jones Industrial Average
  • Next earnings date: 2026-07-30

More on the Procter & Gamble shares in social media

This text is for informational purposes only and does not constitute investment advice, an offer or a solicitation to buy or sell any financial instrument. Historical performance is not a reliable indicator of future results. Readers should conduct their own research or consult a qualified financial advisor before making investment decisions.

en | US7427181091 | PROCTER & GAMBLE | boerse | 69615689 | bgmi